ciprofloxacin has been researched along with Hematochezia in 22 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Hematochezia: The passage of bright red blood from the rectum. The blood may or may not be mixed with formed stool in the form of blood, blood clots, bloody stool or diarrhea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Once weekly ciprofloxacin was as effective as daily norfloxacin for the prevention of SBP in cirrhotic patients with ascites." | 9.27 | Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial. ( Jang, JY; Jung, YK; Kim, BI; Kim, HS; Kim, YS; Lee, YR; Park, SY; Seo, YS; Suh, SJ; Um, SH; Yim, HJ; Yim, SY, 2018) |
| "Once weekly ciprofloxacin was as effective as daily norfloxacin for the prevention of SBP in cirrhotic patients with ascites." | 5.27 | Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial. ( Jang, JY; Jung, YK; Kim, BI; Kim, HS; Kim, YS; Lee, YR; Park, SY; Seo, YS; Suh, SJ; Um, SH; Yim, HJ; Yim, SY, 2018) |
| "In cirrhotic patients with variceal bleeding and with Child-Pugh class B or C, the use of intravenous ciprofloxacin for 3 days after EVL was not only effective in the prevention of bacterial infections but also cost-effective." | 5.10 | [Prospective randomized trial of intravenous ciprofloxacin for prevention of bacterial infection in cirrhotic patients with esophageal variceal bleeding]. ( Choi, KW; Choi, MS; Hong, SN; Kim, BJ; Kim, JJ; Koh, KC; Lee, CY; Lee, JH; Lee, SY; Paik, SW; Rhee, JC; Rhee, PL; Ryu, MK, 2002) |
| " The aim of this study was to investigate the efficacy of prophylactic intestinal decontamination with oral ciprofloxacin for the prevention of bacterial infections in cirrhotic patients with upper gastrointestinal bleeding." | 5.08 | The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. ( Chang, FY; Hou, MC; Hsieh, WJ; Hwang, SJ; Lee, FY; Lee, SD; Lin, HC, 1998) |
| " For primary prophylaxis, short-term antibiotic treatment (oral norfloxacin or ciprofloxacin) is indicated in cirrhotic patients (with or without ascites) admitted with gastrointestinal haemorrhage (variceal or non-variceal)." | 4.84 | [Bacterial infections in liver cirrhosis]. ( Farkas, A; Papp, M; Tornai, I; Udvardy, M, 2007) |
| "We performed sequential, targeted safety monitoring in three known drug/adverse event (AE) pairs: (i) paroxetine/upper gastrointestinal (UGI) bleed; (ii) lisinopril/angioedema; (iii) ciprofloxacin/Achilles tendon rupture (ATR)." | 3.78 | Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examples. ( Avorn, J; Bohn, RL; Daniel, GW; Eisenberg, DF; Gagne, JJ; Patrick, AR; Rassen, JA; Rodgers, JK; Schneeweiss, S; Wahl, PM; Wasser, TE; Wilson, M, 2012) |
| "Bacterial infections are common in cirrhotic patients with acute variceal bleeding, occurring in 20% within 48 h." | 2.50 | Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding. ( Lee, YY; Mahadeva, S; Tee, HP, 2014) |
| "Four patients had had cervical cancer, five had uterine cancer, one had prostatic cancer, one had vesical cancer and one had vaginal cancer." | 1.37 | A novel treatment for haemorrhagic radiation proctitis using colonic irrigation and oral antibiotic administration. ( Atittharnsakul, P; Patiwongpaisarn, A; Rojanasakul, A; Sahakitrungruang, C; Thum-Umnuaysuk, S, 2011) |
| "The development of toxic megacolon as a complication of infectious colitis is rare." | 1.33 | Toxic megacolon complicating Escherichia coli O157 infection. ( Koerner, RJ; McElroy, J; Nayar, DM; Pai, P; Vetrivel, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 12 (54.55) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Bohossian, HB | 1 |
| Lopes, EW | 1 |
| Roller, LA | 1 |
| Ananthakrishnan, AN | 1 |
| Zukerberg, LR | 1 |
| Yim, HJ | 1 |
| Suh, SJ | 1 |
| Jung, YK | 1 |
| Yim, SY | 1 |
| Seo, YS | 1 |
| Lee, YR | 1 |
| Park, SY | 1 |
| Jang, JY | 1 |
| Kim, YS | 1 |
| Kim, HS | 2 |
| Kim, BI | 2 |
| Um, SH | 1 |
| Lee, YY | 1 |
| Tee, HP | 1 |
| Mahadeva, S | 1 |
| Boesler, B | 1 |
| Ott, M | 1 |
| Menges, M | 1 |
| Yagnik, VD | 1 |
| Sahakitrungruang, C | 2 |
| Thum-Umnuaysuk, S | 1 |
| Patiwongpaisarn, A | 2 |
| Atittharnsakul, P | 2 |
| Rojanasakul, A | 1 |
| Werner, CR | 1 |
| Riessen, R | 1 |
| Gregor, M | 1 |
| Bitzer, M | 1 |
| Fukui, H | 1 |
| Kim, HJ | 1 |
| Park, JH | 1 |
| Park, DI | 1 |
| Cho, YK | 1 |
| Sohn, CI | 1 |
| Jeon, WK | 1 |
| Kim, DJ | 1 |
| Sugimoto, S | 1 |
| Yoshimura, Y | 1 |
| Tachikawa, N | 1 |
| Sonnevend, Á | 1 |
| Kovács, J | 1 |
| Pál, T | 1 |
| Akawi, N | 1 |
| Nagelkerke, N | 1 |
| Schneider, G | 1 |
| Wahl, PM | 1 |
| Gagne, JJ | 1 |
| Wasser, TE | 1 |
| Eisenberg, DF | 1 |
| Rodgers, JK | 1 |
| Daniel, GW | 1 |
| Wilson, M | 1 |
| Schneeweiss, S | 1 |
| Rassen, JA | 1 |
| Patrick, AR | 1 |
| Avorn, J | 1 |
| Bohn, RL | 1 |
| Kanjanasilp, P | 1 |
| Malakorn, S | 1 |
| Arora, A | 1 |
| Saluja, SS | 1 |
| Bhardwaj, V | 1 |
| Singh, M | 1 |
| Singh, A | 1 |
| Puri, AS | 1 |
| Hong, SN | 1 |
| Kim, BJ | 1 |
| Lee, SY | 1 |
| Lee, CY | 1 |
| Ryu, MK | 1 |
| Choi, MS | 1 |
| Lee, JH | 1 |
| Rhee, PL | 1 |
| Koh, KC | 1 |
| Kim, JJ | 1 |
| Paik, SW | 1 |
| Rhee, JC | 1 |
| Choi, KW | 1 |
| Nayar, DM | 1 |
| Vetrivel, S | 1 |
| McElroy, J | 1 |
| Pai, P | 1 |
| Koerner, RJ | 1 |
| Song, JY | 1 |
| Jung, SJ | 1 |
| Park, CW | 1 |
| Sohn, JW | 1 |
| Kim, WJ | 1 |
| Kim, MJ | 1 |
| Cheong, HJ | 1 |
| Papp, M | 1 |
| Farkas, A | 1 |
| Udvardy, M | 1 |
| Tornai, I | 1 |
| Jaspersen, D | 1 |
| Rumpf, KD | 1 |
| Bässler, R | 1 |
| Bonzel, T | 1 |
| Hammar, CH | 1 |
| Gerbes, AL | 1 |
| Hsieh, WJ | 1 |
| Lin, HC | 1 |
| Hwang, SJ | 1 |
| Hou, MC | 1 |
| Lee, FY | 1 |
| Chang, FY | 1 |
| Lee, SD | 1 |
| Linville, D | 1 |
| Emory, C | 1 |
| Graves, L | 1 |
3 reviews available for ciprofloxacin and Hematochezia
| Article | Year |
|---|---|
Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; Endoscopy; Esoph | 2014 |
[A case of repeated upper gastrointestinal bleeding secondary to Legionella pneumonia].
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Female; Gastrointestinal Hemorrhage; Humans; Legionnaire | 2011 |
[Bacterial infections in liver cirrhosis].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ascites; | 2007 |
6 trials available for ciprofloxacin and Hematochezia
| Article | Year |
|---|---|
Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Ascites; Bacterial Infections; Ciprofloxacin; Disease-Free Survi | 2018 |
Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Infections; Bacterial Translocation; C | 2011 |
A randomized controlled trial comparing colonic irrigation and oral antibiotics administration versus 4% formalin application for treatment of hemorrhagic radiation proctitis.
Topics: Administration, Oral; Administration, Rectal; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; | 2012 |
[Prospective randomized trial of intravenous ciprofloxacin for prevention of bacterial infection in cirrhotic patients with esophageal variceal bleeding].
Topics: Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; End | 2002 |
[Antibiotic prophylaxis after gastrointestinal hemorrhage in liver cirrhosis--for which patients, with what antibiotics?].
Topics: Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bacterial Infections; Ciprofl | 1997 |
The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fem | 1998 |
13 other studies available for ciprofloxacin and Hematochezia
| Article | Year |
|---|---|
Case 8-2020: An 89-Year-Old Man with Recurrent Abdominal Pain and Bloody Stools.
Topics: Abdominal Pain; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Clostridium Infections; Col | 2020 |
Segmental haemorrhagic colitis under ciprofloxacin therapy.
Topics: Anti-Infective Agents; Biopsy; Ciprofloxacin; Colitis, Ulcerative; Colonoscopy; Diagnosis, Different | 2009 |
Response: A case of massive gastrointestinal haemorrhage (ANZ J. Surg. 2010: 80; 190-1).
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Dose-Response Relationship, Drug; Dr | 2010 |
A novel treatment for haemorrhagic radiation proctitis using colonic irrigation and oral antibiotic administration.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Combined Modality Therapy; Female; Ga | 2011 |
[Unexpected complication following esophageal variceal hemorrhage - Case 2/2011].
Topics: Amiodarone; Anti-Bacterial Agents; Ciprofloxacin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inh | 2011 |
How leaky gut and endotoxemia induce bacterial infection in cirrhosis and gastrointestinal hemorrhage?
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bacterial Translocation; Cephalos | 2011 |
Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Campylobacter Infections; Campylobacter jejuni; | 2011 |
Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examples.
Topics: Achilles Tendon; Adverse Drug Reaction Reporting Systems; Algorithms; Angioedema; Anti-Infective Age | 2012 |
Malakoplakia masquerading as ulcerative colitis in an immunocompetent child.
Topics: Adolescent; Ciprofloxacin; Colectomy; Colitis, Ulcerative; Colonoscopy; Diagnosis, Differential; Gas | 2014 |
Toxic megacolon complicating Escherichia coli O157 infection.
Topics: Adult; Anti-Infective Agents; Antibodies, Bacterial; Ciprofloxacin; Colitis; Colon; Escherichia coli | 2006 |
Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ciprofloxacin; Community-Acquired Inf | 2006 |
[Life-threatening arterial bleeding in hemorrhagic-necrotizing salmonella ileitis].
Topics: Adult; Anastomosis, Surgical; Cecum; Ciprofloxacin; Colon; Gastrointestinal Hemorrhage; Humans; Ilei | 1993 |
Ciprofloxacin and warfarin interaction.
Topics: Aged; Ciprofloxacin; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Stomach Ulcer; | 1991 |